Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples
- 25 May 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 804 (2), 431-434
- https://doi.org/10.1016/j.jchromb.2004.01.032
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2003
- U.S. Food and Drug Administration Drug Approval Summaries: Imatinib Mesylate, Mesna Tablets, and Zoledronic AcidThe Oncologist, 2002
- Quantification of the anti-leukemia drug STI571 (Gleevec™) and its metabolite (CGP 74588) in monkey plasma using a semi-automated solid phase extraction procedure and liquid chromatography-tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2002
- High-throughput quantification of the anti-leukemia drug STI571 (Gleevec™) and its main metabolite (CGP 74588) in human plasma using liquid chromatography–tandem mass spectrometryJournal of Chromatography B, 2002
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2001
- In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase InhibitorJNCI Journal of the National Cancer Institute, 1999
- Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces ApoptosisBlood Cells, Molecules, and Diseases, 1997
- CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion ProteinsBlood, 1997
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996
- Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.JCI Insight, 1992